argenx SE Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
argenx SE (ARGX) holds an ST Score of 67.4 out of 100 (B), with its strongest factor being Profitability (A+) and its weakest Valuation (F). Analysts rate ARGX Buy across 36 ratings with a $1165.29 average price target (+0.2% vs the current $988.20).
- Strongest
- ProfitabilityA+
- Weakest
- ValuationF
All factor grades
- ProfitabilityA+
- MomentumA+
- GrowthA+
- ForecastB+
- Financial StrengthB-
- ValuationF
- Piotroski5/9
Contact
ARGX stock: frequently asked questions
What is ARGX's ST Score?
argenx SE (ARGX) has an ST Score of 67.4 out of 100, an overall grade of B. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ARGX a buy, sell, or hold?
Wall Street's consensus rating on ARGX is Buy based on 36 analyst ratings. Our own ST Score grades it B (67.4/100). This is data, not investment advice — always do your own research.
What is ARGX's valuation grade?
argenx SE (ARGX) earns a valuation grade of F, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ARGX's growth grade?
argenx SE (ARGX) earns a growth grade of A+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ARGX's profitability grade?
argenx SE (ARGX) earns a profitability grade of A+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ARGX's financial strength grade?
argenx SE (ARGX) earns a financial strength grade of B-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ARGX?
The average analyst price target for argenx SE (ARGX) is $1165.29 from 36 analysts, which is +0.2% versus the recent price of $988.20.
What is ARGX's Piotroski score?
argenx SE (ARGX) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.